NH Nongwoobio Co., Ltd. (KOSDAQ:054050)
7,010.00
-90.00 (-1.27%)
At close: Oct 8, 2026
NH Nongwoobio Revenue
NH Nongwoobio had revenue of 46.10B KRW in the quarter ending June 30, 2026, with 6.35% growth. This brings the company's revenue in the last twelve months to 160.53B, up 5.99% year-over-year. In the year 2025, NH Nongwoobio had annual revenue of 158.79B with 9.75% growth. That makes NH Nongwoobio the 21,271st largest company in the world by revenue and 1,160th in South Korea.
Revenue (ttm)
160.53B
Revenue Growth
+5.99%
P/S Ratio
0.70
Revenue / Employee
482.06M
Employees
333
Market Cap
112.37B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 158.79B | 14.11B | 9.75% |
| Dec 31, 2024 | 144.68B | 8.84B | 6.50% |
| Dec 31, 2023 | 135.84B | 2.44B | 1.83% |
| Dec 31, 2022 | 133.40B | 557.04M | 0.42% |
| Dec 31, 2021 | 132.84B | 2.81B | 2.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Deutsch Motors | 2.66T |
| TOVIS Co.,Ltd | 678.06B |
| UIL Co., Ltd. | 389.05B |
| Hyundai Everdigm | 303.93B |
| Amogreentech Co.,Ltd | 126.96B |
| Solborn | 125.03B |
| OPTUS Pharmaceutical | 94.47B |
| WooriNet | 69.43B |
NH Nongwoobio News
- 1 month ago - NH Nongwoobio Quarterly report: Q2 2026 - Filings
- 5 months ago - NH Nongwoobio Quarterly report: Q1 2026 - Filings
- 6 months ago - NH Nongwoobio Annual report: Q4 2025 - Filings
- 6 months ago - NH Nongwoobio Quarterly report: Q4 2025 - Filings
- 11 months ago - NH Nongwoobio Quarterly report: Q3 2025 - Filings